David A. Sinclair

Co-founder and Board Chair, Life Biosciences; Professor of Genetics, Harvard Medical School

Appears in 1 story

Born: June 26, 1969, Sydney

Education: University of New South Wales, St Ives High School

Last updated Nov 1, 2026

Stories

First human trial of cellular rejuvenation therapy begins after two decades of research

New Capabilities

As of May 2026: Leading the scientific vision behind the first human reprogramming trial

In 2006, Shinya Yamanaka showed that four genes could rewind an adult cell all the way back to an embryonic-like state. Twenty years later, a stripped-down version of that technique is being injected into human eyes for the first time.

Updated May 30